Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)
China
· Delayed Price · Currency is CNY 56.38
-2.01 (-3.44%)
Apr 29, 2026, 3:04 PM CST
SHE:300347 Revenue
Hangzhou Tigermed Consulting had revenue of 1.80B CNY in the quarter ending March 31, 2026, with 15.17% growth. This brings the company's revenue in the last twelve months to 7.07B, up 8.65% year-over-year. In the year 2025, Hangzhou Tigermed Consulting had annual revenue of 6.83B with 3.48% growth.
Revenue (ttm)
7.07B
Revenue Growth
+8.65%
P/S Ratio
6.44
Revenue / Employee
635.23K
Employees
11,130
Market Cap
45.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.83B | 229.68M | 3.48% |
| Dec 31, 2024 | 6.60B | -780.92M | -10.58% |
| Dec 31, 2023 | 7.38B | 298.57M | 4.21% |
| Jan 1, 2023 | 7.09B | 1.87B | 35.91% |
| Jan 1, 2022 | 5.21B | 2.02B | 63.32% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Joinn Laboratories(China)Co.,Ltd. | 1.66B |
| BGI Genomics | 3.84B |
| Guangzhou Kingmed Diagnostics Group | 5.91B |
| Dian Diagnostics Group | 10.10B |
| Amoy Diagnostics | 1.20B |
| Shanghai Runda Medical Technology | 7.40B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| WuXi AppTec | 43.42B |